` GDRX (Goodrx Holdings Inc) vs S&P 500 Comparison - Alpha Spread

GDRX
vs
S&P 500

Over the past 12 months, GDRX has underperformed S&P 500, delivering a return of -42% compared to the S&P 500's 9% growth.

Stocks Performance
GDRX vs S&P 500

Loading
GDRX
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
GDRX vs S&P 500

Loading
GDRX
S&P 500
Difference
www.alphaspread.com

Performance By Year
GDRX vs S&P 500

Loading
GDRX
S&P 500
Add Stock

Competitors Performance
Goodrx Holdings Inc vs Peers

S&P 500
GDRX
VEEV
PME
DOCS
2413
Add Stock

Goodrx Holdings Inc
Glance View

Economic Moat
None
Market Cap
1.6B USD
Industry
Health Care

GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies. The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.

GDRX Intrinsic Value
11.02 USD
Undervaluation 59%
Intrinsic Value
Price
Back to Top